Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symptomatic treatment of pollen-related allergic rhinoconjunctivitis in children and its relation with asthma
2012-001591-11Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Jul 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC) and asthma comparing Levocetirizine with Fluticasone (2 arms). Primary endpoint: Research Question 1. Started Jul 2012; status: active.
02
Drugs
levocetirizinefluticasone
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)asthma
Beyond the preview
Go deeper on 2012-001591-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001591-11.